Caricamento...
DDIS-03. HARNESSING siRNA NANOMEDICINE FOR THERAPEUTIC GENE SILENCING IN GLIOBLASTOMA
GBM is the most common primary brain tumor in adults, with a very poor prognosis. Despite tremendous efforts to develop new drugs, the treatment of GBM remains a great challenge. The use of nanoparticles (NPs) has emerged as a potential strategy for diagnosis and treatment of tumors, GBM especially....
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692115/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.239 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|